Assenagon Asset Management S.A. / TMO
Assenagon Asset Management S.A.’s Thermo Fisher Scientific Inc Position
Does Assenagon Asset Management S.A. own Thermo Fisher Scientific Inc (TMO)? Yes — 341.8K shares worth $171M (+0.21% of its 13F portfolio) as of Q2 2026, up from 186.4K shares the prior filed quarter.
Position Value
$171M
Q2 2026
Shares
341.8K
% of Portfolio
+0.21%
Quarters Held
31
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 341.8K | $171M | +0.21% |
| Q1 2026 | 186.4K | $92M | +0.14% |
| Q4 2025 | 10.7K | $6M | +0.01% |
| Q3 2025 | 615.3K | $298M | +0.41% |
| Q2 2025 | 41.6K | $17M | +0.03% |
| Q1 2025 | 153.7K | $76M | +0.13% |
| Q4 2024 | 20.0K | $10M | +0.02% |
| Q3 2024 | 51.0K | $32M | +0.06% |
| Q2 2024 | 472.0K | $261M | +0.58% |
| Q1 2024 | 49.6K | $29M | +0.07% |
| Q4 2023 | 104.7K | $56M | +0.15% |
| Q3 2023 | 91.7K | $46M | +0.14% |
| Q2 2023 | 38.1K | $20M | +0.07% |
| Q1 2023 | 320.5K | $185M | +0.66% |
| Q4 2022 | 215.6K | $119M | +0.43% |
| Q3 2022 | 141.7K | $72M | +0.28% |
| Q2 2022 | 50.4K | $27M | +0.10% |
| Q1 2022 | 237.6K | $140M | +0.39% |
| Q4 2021 | 67.5K | $45M | +0.13% |
| Q3 2021 | 158.1K | $90M | +0.29% |
| Q2 2021 | 74.0K | $37M | +0.13% |
| Q1 2021 | 110.7K | $51M | +0.21% |
| Q4 2020 | 121.2K | $56M | +0.25% |
| Q3 2020 | 2.2K | $959,000 | +0.01% |
| Q2 2020 | 49.1K | $18M | +0.11% |
| Q1 2020 | 186.6K | $53M | +0.42% |
| Q4 2019 | 6.2K | $2M | +0.01% |
| Q3 2019 | 155.0K | $45M | +0.30% |
| Q2 2019 | 105.2K | $31M | +0.23% |
| Q1 2019 | 77.9K | $21M | +0.20% |
| Q4 2018 | 56.7K | $13M | +0.14% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Assenagon Asset Management S.A.’s full portfolio or all institutional holders of TMO.